$CROX

Crocs Q3 Revenue Rises 4.6% to $1.04 Billion; Raises 2026 Outlook

Crocs reported Q3 2026 revenue of $1.04 billion, up 4.6% YoY, with adjusted EPS of $3.69. The company raised its full-year 2026 revenue growth outlook to 3% and adjusted EPS guidance to $14.45–$14.65. Crocs Brand revenue grew 4.4%, while HEYDUDE returned to growth with a 6.1% increase. The company repurchased 2.0 million shares and repaid $21 million in debt.

Original reporting
Published Oct 29, 2026, 11:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 11:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crocs Q3 Revenue Rises 4.6% to $1.04 Billion; Raises 2026 Outlook — source image
Decision brief

The 30-second read

$CROXBullishMed
01

Why it matters

The earnings beat and guidance lift provide a fresh catalyst that could attract short‑term buying interest.

02

Market read

Earnings beat and raised outlook create a positive short‑term trading opportunity for CROX and may lift the broader consumer discretionary sector.

03

What to watch

Potential headwinds from declining North American sales and macro consumer spending trends.

Relevance 7/10Novelty 7/10Timing: post‑market today

Background

Crocs' Q3 results show modest top‑line growth and a shift toward higher profitability, with a share repurchase program of 2 M shares.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Crocs reported Q3 2026 revenue of $1.04 B, up 4.6% YoY, and raised full‑year revenue growth outlook to ~3% with EPS guidance of $14.45‑$14.65.

Expected impact

likely upward pressure as investors price in higher revenue and EPS outlook

Evidence & confidence

Guidance raise is a fresh, material update for a mid‑cap consumer brand, creating a clear trading catalyst.

Market effects

May boost sentiment for discretionary apparel and footwear peers.

U.S. consumer discretionary sector could see modest gains.

Limited to U.S. markets; no broader macro impact.

Counterpoint

If the guidance raise is already priced in, the stock could face a pull‑back on earnings beat.

Key entities

  • Crocs, Inc.

    U.S. footwear and apparel maker (ticker CROX).

Related articles

$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

$CROXMed

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.